Semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference
View as a Web Page
News Medical
 
  Endocrinology Endocrinology logo  
  The latest endocrinology news from News Medical  
 GLP-1 receptor activation linked to lower depression and bipolar disorder oddsGLP-1 receptor activation linked to lower depression and bipolar disorder odds
 
Genetic analyses linked BMI-related GLP-1 receptor activation to better mental well-being and lower odds of major depressive disorder and bipolar disorder. The findings do not prove that GLP-1 receptor agonist drugs treat psychiatric conditions, and randomized clinical trials are still needed.
 
 
 Semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk differenceSemaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference
 
Researchers compared semaglutide with liraglutide in 57,456 insured adults without recorded diabetes or cardiovascular disease who initiated formulations indicated for chronic weight management. Semaglutide users had a lower risk of incident diabetes, particularly beyond six months of follow-up, but limited cardiovascular events prevented a precise comparison of cardiovascular risk.
 
   Gut microbial metabolites may shape vulnerability to stress-related mental disordersGut microbial metabolites may shape vulnerability to stress-related mental disorders
 
Gut microbiome-derived metabolites may influence stress-related mental disorders through neural, immune, endocrine, and epigenetic pathways. Evidence is strongest for depression and preclinical models, while larger longitudinal human studies are needed to establish causality and clinical value.
 
   Breast and prostate cancer survival worsens with metabolic syndromeBreast and prostate cancer survival worsens with metabolic syndrome
 
A SEER-Medicare analysis of more than 200,000 adults aged 66 and older found that metabolic syndrome was associated with about twice the adjusted hazard of death from any cause after breast or prostate cancer. The condition was also linked to higher cancer-specific, cardiovascular-specific, and liver-failure-specific mortality, although the observational design prevents causal conclusions.
 
   Semaglutide fuels rapid growth in US GLP-1RA use as payments riseSemaglutide fuels rapid growth in US GLP-1RA use as payments rise
 
Nationally representative US data show GLP-1RA use rose 230% among adults with diabetes and 643% among those without reported diabetes between 2017 and 2022, largely driven by semaglutide. Mean annual out-of-pocket payments decreased, but mean total annual payments per user increased, raising concerns about long-term affordability.
 
 GLP-1 weight-loss drugs may also reduce binge eating
 
GLP-1 weight-loss drugs may also reduce binge eatingResearch indicates GLP-1RAs may effectively reduce binge eating severity, offering a complementary approach to existing psychological therapies for obesity.
 
 
 Popular diabetes drugs do not alter the risk of developing a blinding eye condition
 
Popular diabetes drugs do not alter the risk of developing a blinding eye conditionAn estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of medication that mimics the GLP-1 hormone - to lower blood sugar and support weight loss. Some research has suggested that their use can reduce the risk of developing other diseases.
 
 
 Researchers identify immune cell receptor that drives organ aging process
 
Researchers identify immune cell receptor that drives organ aging processWe may age at different rates, but none of us escapes aging. A study in mice and in human cells by Stanford Medicine researchers pins much of the blame on a particular type of immune cell's increased inability, with advancing age, to gobble up another immune cell type.
 
 
 Thymus hormone identified as key player in reversing age-related inflammation
 
Thymus hormone identified as key player in reversing age-related inflammationChronic, low-grade inflammation in the body-a phenomenon known as "inflammaging" because it increases with age-has been linked to many of today's leading causes of illness and death, including cancer, heart disease, metabolic conditions and neurodegenerative diseases.
 
 
 Evening chronotype links later eating with higher body fat
 
Evening chronotype links later eating with higher body fatResearch shows evening chronotypes in women consume more energy later, leading to higher body fat and metabolic issues, highlighting chrono-nutrition's role.
 
 
 Researchers propose simple finger prick test to track metabolic health
 
Researchers propose simple finger prick test to track metabolic healthResearchers writing in Frontiers in Science propose using simple tests to track metabolic health in non-communicable diseases, which cause three in four deaths worldwide.
 
 
 Weight loss drugs may reduce binge eating disorder symptoms
 
Weight loss drugs may reduce binge eating disorder symptomsDrugs commonly used for weight loss, known as GLP-1 receptor agonists, have been found to reduce the key symptoms of binge eating disorder, in a new review of evidence led by University College London (UCL) researchers.
 
 
 Lactoferrin yogurt helps preserve iron stores in women with gestational diabetes
 
Lactoferrin yogurt helps preserve iron stores in women with gestational diabetesIn a double-blind pilot trial, lactoferrin-enriched yogurt added to routine iron supplementation helped prevent ferritin decline in pregnant women with gestational diabetes and reduced iron stores. The intervention was well tolerated and produced modest changes in selected gut bacteria, but did not significantly improve anemia or metabolic outcomes.
 
 
 Experimental drug shows promise against NRAS-driven melanoma
 
Experimental drug shows promise against NRAS-driven melanomaA research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a groundbreaking pathway-targeted therapy could be an effective treatment for certain melanoma patients and fill an unmet clinical need for patients with advanced disease.
 
 
 Bile acid buildup linked to aggressive breast cancer progression
 
Bile acid buildup linked to aggressive breast cancer progressionA buildup of bile acids caused by an unhealthy gut can drive breast cancer to other parts of the body, new University of Virginia Comprehensive Cancer Center research reveals.
 
 
 Experimental KRAS vaccine safely generates durable immune response against pancreatic cancer
 
Experimental KRAS vaccine safely generates durable immune response against pancreatic cancerResearchers at the Johns Hopkins Kimmel Cancer Center and its Skip Viragh Center for Pancreatic Cancer report that an experimental vaccine targeting mutant KRAS, one of the most common genetic drivers of pancreatic cancer, was safe and generated durable immune responses aimed at preventing the cancer in people at high risk.
 
 
 New guideline offers recommendations for testosterone replacement therapy use
 
New guideline offers recommendations for testosterone replacement therapy useThe Society's Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing and prescribing practices.
 
 
 Experts recommend renaming PCOS to better reflect whole-body impacts
 
Experts recommend renaming PCOS to better reflect whole-body impactsA condition affecting approximately 170 million adolescents and women worldwide has a new name – one that better reflects its complexity and far-reaching health impacts.
 
 
 Blood-based gene tests show promise for pancreatic cancer screening
 
Blood-based gene tests show promise for pancreatic cancer screeningResearchers at Kanazawa University report the blood-based gene expression tests may enable early pancreatic cancer screening and improve long-term survival.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026